National Institute of Immunology receives trademark for India’s first indigenous tumor antigen SPAG9 - Job Community
Responsive Ads Here

Post Top Ad

Your Ad Spot

Monday, 7 June 2021

National Institute of Immunology receives trademark for India’s first indigenous tumor antigen SPAG9

SPAG9 antigen which has been developed by the National Institute of Immunology (NII) has received the ASPAGNIITM trademark.



from Jagran Josh https://ift.tt/3g1ByfP

No comments:

Post a Comment

Post Top Ad

Your Ad Spot